Three-plane CCI comparable with single-plane outcomes

Article

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

The 2.75 mm three-plane clear corneal incision (CCI) created with a femtosecond (FS) laser produces comparable outcomes to single-plane angled manual incision for anterior and posterior corneal topography, claims a new study.

Dr Marco Lombardo et al., Fondazione G.B. Bietti IRCCS, Rome, Italy, performed inflation testing in 14 human eye globes to assess the topographic response to the cornea to CCIs.

The eyes were divided into two group, with first group undergoing a 2.75 mm three-plane CCI created with an FS laser and the control group receiving a 2.75 mm manual CCI using disposable angled knives.

A Scheimpflug topographer was used to obtain topographic maps of the anterior and posterior cornea, keratometric data was used to evaluate the curvature changes of the cornea and vector analysis was used to identify the changes of corneal astigmatism.

The mean postoperative change of the anterior keratometric power was 0.04 ± 0.39 and 0.05 ± 0.51 in the FS laser and control groups, respectively and the mean change of the posterior corneal keratometric power was 0.16 ± 0.19 and 0.15 ± 0.18 D, respectively.

It was found that the average change of the anterior and posterior corneal astigmatism vector magnitude was 0.17 D or less in both groups. The team also recorded an insignificant against-the-rule astigmatic change in the anterior and posterior corneal interfaces after both CCI techniques.

To read the abstract please visit the Journal of Refractive Surgery.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
© 2024 MJH Life Sciences

All rights reserved.